Clinical trial
A Multicenter, Randomized, Double-Blind, Placebo- and Active-Controlled Parallel-Group Phase II/III Clinical Trial to Evaluate the Efficacy and Safety of HL-1186 Tablets for Postoperative Analgesia in Orthopedic Surgery
NCT07699601 is registered in ClinicalTrials.gov with Shanghai Huilun Pharmaceutical Co., Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multicenter, Randomized, Double-Blind, Placebo- and Active-Controlled Parallel-Group Phase II/III Clinical Trial to Evaluate the Efficacy and Safety of HL-1186 Tablets for Postoperative Analgesia in Orthopedic Surgery
- Lead sponsor
- Shanghai Huilun Pharmaceutical Co., Ltd.
- Phase
- Phase 2/3
- Overall status
- Recruiting
- Start date
- May 9, 2026
- Completion date
- December 31, 2026
- Enrollment
- 330 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.